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G protein-coupled receptors (GPCRs) can initiate intracellu-
lar signaling cascades by coupling to an array of heterotrimeric
G proteins and arrestin adaptor proteins. Understanding the
contribution of each of these coupling options to GPCR signal-
ing has been hampered by a paucity of tools to selectively per-
turb receptor function. Here we employ CRISPR/Cas9 genome
editing to eliminate selectedGproteins (Gq andG11) or arres-
tin2 and arrestin3 fromHEK293 cells togetherwith the elimina-
tion of receptor phosphorylation sites to define the relative
contribution of G proteins, arrestins, and receptor phosphor-
ylation to the signaling outcomes of the free fatty acid recep-
tor 4 (FFA4). A lack of FFA4-mediated elevation of intracel-
lular Ca2 in Gq/G11-null cells and agonist-mediated
receptor internalization in arrestin2/3-null cells confirm-
ed previously reported canonical signaling features of this
receptor, thereby validating the genome-edited HEK293 cells.
FFA4-mediated ERK1/2 activation was totally dependent on
Gq/11 but intriguingly was substantially enhanced for FFA4
receptors lacking sites of regulated phosphorylation. This was
not due to a simple lack of desensitization of Gq/11 signaling
because the Gq/11-dependent calcium response was desensi-
tized by both receptor phosphorylation and arrestin-dependent
mechanisms, whereas a substantially enhanced ERK1/2
response was only observed for receptors lacking phosphoryla-
tion sites and not in arrestin2/3-null cells. In conclusion, we
validate CRISPR/Cas9 engineered HEK293 cells lacking Gq/11
or arrestin2/3 as systems for GPCR signaling research and
employ these cells to reveal a previously unappreciated interplay
of signaling pathways where receptor phosphorylation can
impact on ERK1/2 signaling through a mechanism that is likely
independent of arrestins.
In recent years the concept that G protein-coupled receptors
(GPCRs)3 mediate their effects exclusively via activation of one
ormoremembers of the family of heterotrimericGproteins has
been shown to be incorrect (1). Although such canonical sig-
naling via G proteins is integral to the regulation of second
messenger production, a substantial number of intracellular
adaptor proteins can also interact either directly or as part of
larger protein complexes with GPCRs to modify downstream
signal transduction and control physiological functions. The
most studied of such adaptor proteins are members of the
arrestin family (2–4), and it is clear despite being named origi-
nally for their capacity to “arrest” and, therefore, block G pro-
tein-mediated signaling that they can regulate positively many
cellular functions in a GPCR-dependentmanner (2–4). A great
deal of our understanding of the roles of arrestin2 and arrestin3
(frequently still designated-arrestin1 and-arrestin2, respec-
tively) has derived either from studies employing arrestin iso-
form-nullmice (5, 6) and tissues and cells derived from themor,
in the absence of useful chemical inhibitors of the arrestins, the
application of siRNAand related technologies to reduce steady-
state levels of these proteins. Although useful, the inability to
completely abolish expression of arrestins in such “knock-
down” studies compromises quantitative interpretation. This is
particularly so given that the end points of arrestin signaling are
often downstreamof highly amplified signal transduction path-
ways, for example within intracellular serine/threonine kinase
cascades. Thus, knockdown experiments that leave even a
modest amount of arrestin expression may still maintain suffi-
cient amounts of an arrestin to produce a near full signal or
function. An alternative strategy is to use mouse embryo fibro-
blasts derived from arrestin-null animals (7–9), but these cells
are challenging to transfect, limiting their usefulness. This has
meant that despite the caveats described above and the fact that
such arrestin-null mouse embryo fibroblasts have shown that,
in this cell type, activation of the extracellular signal-regulated
kinases ERK1/2 by certain ligands at the 2-adrenoreceptor
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requires an arrestin (10), much of the basis of underpinning
analysis of arrestin signaling has derived from studies in more
tractable, transformed cell lines, including human embryonic
kidney (HEK) 293 cells where arrestin levels have been reduced
but not completely eliminated (11–14).
In an effort to define more fully specific roles of G protein
versus arrestin signaling in response to activation of free fatty
acid receptor 4 (FFA4, also called GPR120) (15, 16), we
employed CRISPR/Cas9-mediated genome-editing (17, 18) to
produce HEK293 cell clones that are null for either Gq and
G11, the pair of G proteins that transmit receptor activation to
phosphoinositidase C and thence the elevation of intracellular
Ca2 (19, 20), or are null for both arrestin2 and arrestin3. Each
of these lines was then further transfected to stably express
either wild type FFA4 or a form of this receptor that cannot be
phosphorylated in response to an agonist ligandbecause each of
the residues in the C-terminal tail that becomes phosphorylat-
ed in the wild type receptor has been mutated to alanine (21,
22). We show that either restricting interaction of FFA4 with
arrestins via this mutational strategy or eliminating expression
of the arrestins results in prolongation of Ca2 signaling via
FFA4, whereas we also show that arrestins do not contribute
directly to FFA4-mediated ERK1/2 MAP kinase phosphoryla-
tion/activation in HEK293 cells. Rather, with a phosphoryla-
tion-deficient formofFFA4, agonist regulationofERK1/2phos-
phorylation ismarkedly enhanced in the absence or presence of
arrestins. By contrast, in cells lacking expression of Gq/G11 or
by chemical inhibition of these G proteins, the FFA4 receptor
fails to activate this pathway (23).
Results
Characterization of HEK293 Cells Lacking Gq and G11 or
Arrestin2 and Arrestin3—CRISPR/Cas9-mediated genome-ed-
iting was used to eliminate expression from HEK293 cells of
either the  subunits of both of the phosphoinositidase C-acti-
vating G proteins Gq and G11 or of both the ubiquitously
expressed arrestin isoforms, arrestin2 and arrestin3. Immuno-
blotting studies performed on membranes from cells selected
to lack expression of both Gq and G11 showed that although
neither of these polypeptides could be detected (Fig. 1, A1 and
1B), this procedure and selection process did not affect signifi-
cantly expression of the  subunits of other G protein subtypes,
including the long and short isoforms of Gs and Gi family
members (Fig. 1, A1 and 1B). Similarly, immunoblotting of
cytosolic preparations from cells selected to lack expression of
both arrestin2 and arrestin3 confirmed that neither of these
proteins could now be detected, although both were present in
the parentalHEK293 cells (Fig. 1,A2).Moreover, elimination of
the arrestins also did not significantly affect expression of G
proteins, including Gq/G11 (Fig. 1, A1 and 1B). As shown
previously (23), ATP, acting at a P2Y purinoceptor expressed
endogenously byHEK293 cells, was unable to cause elevation of
[Ca2]i in Gq/G11-null cells (Fig. 1C), although this was eas-
ily measured in single cell Ca2 imaging studies performed on
parental HEK293 cells (Fig. 1C) and was robustly recapitulated
by reintroduction ofGq into theGq/G11-null cells (Fig. 1C).
By contrast, ATP was able to generate a robust Ca2 response
in arrestin2/3-null cells (Fig. 1D).
We recently defined the sites of agonist-regulated phosphor-
ylation within the C-terminal tail of both mouse (m)FFA4 and
human (h)FFA4 and defined that conversion of these serine
and threonine residues to alanines produces phosphorylation-
deficient (PD) forms of the receptor orthologs (21, 22).
We also recently proposed that detection of agonist-regulated
GPCR phosphorylation using phospho-specific antibodies
could be used as a biomarker for receptor activation (24). Here
we used phospho-specific antibodies against the agonist-regu-
lated phosphorylation sites Thr347 and Ser350 (21, 22) as a
marker for FFA4 activation in genome-edited HEK293 cells.
After stable expression of mFFA4-eYFP in each of parental
HEK293 cells and the Gq/G11 or arrestin2/3 genome-edited
cell lines and selection of individual clones, activation of
mFFA4 by the agonist TUG-891 (25–27) was produced no-
matter the genetic status of the cells (parental or genome-ed-
ited) (Fig. 2A1, upper panels). Internal loading controls for such
studies were provided by concurrent detection of levels of-tu-
bulin that migrates in SDS-PAGE at a position akin to a 50-kDa
marker protein (Fig. 2A1, upper panels). The selectivity of the
FFA4 phospho-specific antibodies used to assess the activation
status of FFA4 was confirmed by the lack of detection of
mFFA4-PD-eYFP, a variant of the receptor lacking phosphor-
ylation sites including Thr347 and Ser350 (Fig. 2A1, upper pan-
els). Measures of the total expression of mFFA4-eYFP and
mFFA4-PD-eYFP, assessed either by immunoblotting with an
anti-eYFP antiserum (Fig. 2A1, lower panels) or by measuring
fluorescence corresponding to enhanced yellow fluorescent
protein (eYFP; Fig. 2A2), showed that each receptor variant was
present at similar levels in parental andGq/G11-nullHEK293
cells but at a somewhat higher level in the arrestin2/3-null cells.
hFFA4 tagged at the C terminus with mVenus (a variant of
eYFP) also showed similar activation by TUG-891 when
expressed stably in either parental or Gq/G11-null HEK293
cells (Fig. 2B). Thus, both mouse and human FFA4 were acti-
vated to promote receptor phosphorylation in a similarmanner
by agonist in parental, Gq/G11-null and arrestin2/3-null
cells.
Distinguishing the Dependence of FFA4 SignalingMediated
via Gq/11, Arrestin2/3, and Receptor Phosphorylation
Coupling to Intracellular Calcium Mobilization—Single cell
Ca2 experiments showed a sharp peak of calcium release upon
agonist stimulation of hFFA4-mVenus in parental cells but not
in Gq/G11-null cells (Fig. 2C). These data are consistent
with our previous studies that established FFA4 coupling to
increases in intracellular calcium through canonical Gq/11-de-
pendent activation of phosphoinositidase C. Further validation
of the loss of canonical Gq/11 signal transduction in the Gq/11-
null cells was established by the lack of calcium response to
stimulation of mFFA4-PD-eYFP (a receptor variant uncoupled
from receptor phosphorylation/arrestin signaling) when ex-
pressed stably in Gq/G11-null cells (Fig. 2D) and defined that
Ca2 signaling is independent of receptor phosphorylation/
arrestin signaling.
Coupling to Inositol Phosphate Signaling—As anticipated
from recognition that Gq and G11 are key transducers of
phosphoinositidaseC signaling inHEK293 cells, upon the addi-
G Protein Versus Arrestin GPCR-mediated Signaling
27148 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 53•DECEMBER 30, 2016
 at G
lasgow
 U
niversity Library on M
arch 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
HE
K2
93
-nu
ll
q/1
1
αG Ar
r2
/3-
nu
ll 
0.0
0.5
1.0
1.5
2.0
         ns
no
rm
al
iz
ed
 d
at
a
 (f
ol
d 
ov
er
 H
E
K
29
3)
HE
K 
29
3
-nu
ll
q/1
1
αG Ar
r2
/3-
nu
ll
0.0
0.5
1.0
1.5
ns
*** ***
no
rm
al
iz
ed
 d
at
a
(fo
ld
 o
ve
r 
H
E
K
29
3)
HE
K2
93
-nu
ll
q/1
1
αG Ar
r2
/3-
nu
ll
0.0
0.5
1.0
1.5
         ns
no
rm
al
iz
ed
 d
at
a
(fo
ld
 o
ve
r 
H
E
K
29
3)
FIGURE 1. Characteristics of Gq/G11 and arrestin2/3-null HEK293 cells. Immunoblotting studies were performed on (A1) membrane preparations of
parental HEK293 cells and clones from genome-edited cells that eliminate expression of Gq G11 or arrestin2 arrestin3. Such samples were probed to
detect expressionof the longand short isoformsofGs, GqG11, andGi1/2.A2, cytosolic preparations fromwild typeHEK293cells andarrestin2/3-null cells
were immunoblotted to detect expression of arrestin2 (upper panel) or arrestin3 (lower panel). Representative immunoblots are displayed in bothA1 andA2. B,
a series of such immunoblotswasquantifiedbydensitometric analysis. Individual results of immunoblots taken fromat least four separate cell preparations are
shown relative to levels detected in parental HEK293 cells. Values from individual experiments are shown as the group means  S.E. ns  not significantly
different; ***, different at p 0.001. C, single cell Ca2 imaging was performed on parental HEK293 cells and on both Gq/G11-null cells and such cells into
whichGqhadbeen re-introduced.ATP (100M)wasaddedat the indicated time.D, studies akin to those inCwereperformed inarrestin2/3-null cells. ATP (100
M) was added at the indicated time.
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tion of TUG-891 wild type forms of both hFFA4 and mFFA4
promoted enhanced accumulation of inositol monophosphates
(IP1) in parental HEK293 cells expressing either hFFA4 (Fig.
3A) or mFFA4 (Fig. 3B). However, this did not occur for the
receptor orthologs expressed in Gq/G11-null HEK293 cells
(Fig. 3, A and B), consistent with the lack of elevation of intra-
cellularCa2 in this situation.Notably, the basal level of IP1was
lower in Gq/G11-null HEK293 cells expressing either human
ormouse FFA4 than in equivalent parentalHEK293 cells (Fig. 3,
A and B), indicative of a degree of constitutive activation of the
x
x
x
x
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Gq/G11-phosphoinositidase C signaling axis for both receptor
orthologs.
Receptor Internalization—In each cell line expressing either
wild type mFFA4 or mFFA4-PD the introduced receptor was
directed effectively to the surface of the cells (Fig. 4). As antic-
ipated from previous studies, the addition of the FFA4 agonist
TUG-891 resulted in internalization of mFFA4-eYFP in paren-
tal HEK293 cells that was both rapid and extensive (Fig. 4, Ai).
This was also the case for mFFA4-eYFP expressed in cells lack-
ingGq/G11 (Fig. 4,Aii). As anticipated from this observation,
pretreatment of parental HEK293 cells expressing mFFA4-
eYFPwith theGq/G11 inhibitorYM-254890 (28–31) also did
not affect agonist-induced internalization of the receptor (Fig.
4, Aiii). In contrast, when mFFA4-PD-eYFP was expressed in
parental HEK293 cells agonist-induced internalization of the
receptor was greatly reduced (Fig. 4, Aiv). Moreover, when
eitherwild type (Fig. 4,Av) ormFFA4-PD-eYFP (Fig. 4,Avi) was
expressed in arrestin2/3-null HEK293 cells, agonist-induced
internalization of the receptor appeared to be all but lacking.
This was also the case for mFFA4-PD-eYFP expressed in Gq/
G11-null cells (Fig. 4,Avii). Cell surface enzyme-linked immu-
nosorbent assay (ELISA) studies detecting the FLAG epitope
tag incorporated into the N-terminal region of each receptor
construct provided quantitation of these effects over time
(Fig. 4B). In support of the cell imaging studies, extensive and
time-dependent reductions in cell surface mFFA4-eYFP were
observed in both parental and Gq/G11-null HEK293 cells. In
contrast, internalization of mFFA4-eYFP expressed in arres-
tin2/3-null HEK293 cells (Fig. 4B) was not evident at early time
points of agonist stimulation with only a small response
observed after 30 min of stimulation (Fig. 4B). These data sup-
port the notion that FFA4 internalization is largely dependent
on arrestin2/3. Interestingly, removal of the phosphorylation
sites from FFA4, a process that almost completely uncouples
the receptor from arrestin interactions (21, 22), totally pre-
vented receptor internalization (Fig. 4B). These data suggest
that FFA4 internalization is independent of Gq/11 signaling but,
rather, is completely dependent on receptor phosphorylation,
which acts primarily to drive receptor internalization through
an arrestin-dependent pathway, although there is aminor com-
ponent that is arrestin-independent. To further validate the
arrestin2/3-null cells as a tool to dissect the role of arrestins in
the internalization of FFA4, we restored TUG-891-induced
FFA4 internalization in arrestin2/3-null cells by transiently
expressing an arrestin3-mCherry fluorescent protein construct
in these cells (Fig. 5).
Gq/11-mediated Calcium Responses Are Desensitized through
Both Receptor Phosphorylation and Arrestin-dependent Mech-
anisms—Wenext considered regulation of [Ca2]i and the con-
tribution of arrestins and/or receptor phosphorylation to the
kinetics and potential desensitization of FFA4. As highlighted,
short term treatment of parental HEK293 cells expressing
mFFA4-eYFP with TUG-891 resulted in rapid elevation of
[Ca2]i, an effect that declined in an essentially mono-expo-
nential fashion, as Ca2 was re-sequestered into intracellular
stores (Fig. 6A). This occurred with a halftime of some 21.5 s
(Table 1). In cells lacking arrestins but expressing wild type
mFFA4-eYFP, after an equally rapid elevation of [Ca2]i upon
the addition of TUG-891, the kinetics of [Ca2]i decline was
substantially slower (halftime 66.6 s) (Fig. 6A, Table 1). Very
extended kinetics of elevated [Ca2]i and very slow decline
toward basal levels were recorded after the addition of TUG-
891 to both wild type HEK293 cells expressing mFFA4-PD-
eYFP and in arrestin2/3-null cells expressingmFFA4-PD-eYFP
FIGURE 2. Wild type but not PD forms of FFA4 became phosphorylated on amino acids Thr347 and Ser350 upon the addition of agonist. Parental,
Gq/G11-null andarrestin2/3-null HEK293 cells stably expressingeithermFFA4-eYFP (left-hand side) ormFFA4-PD-eYFP (right-hand side)were stimulatedwith
vehicle or TUG-891 (10 M, 5 min). Subsequently, cell lysates were resolved by SDS-PAGE and immunoblotted with a mixture of (mouse FFA4 specific)
anti-phospho Thr347-Ser350 (22) and anti--tubulin antibodies, detecting the specific 65-kDa and 50-kDa polypeptides corresponding to the receptor and
-tubulin bands respectively (A1, upper panels). Parallel immunoblots were probed with a mixture of anti-GFP (recognizes also eYFP) and anti--tubulin
antibodies (A1, lower panels). The higher level of TUG-891mediatedmFFA4-eYFP phosphorylation in the arrestin2/3-null HEK293 cells reflects the higher level
expression ofmFFA4 receptor protein in this clone (A1, lower panel). This was confirmed by assessment of eYFP fluorescence in cells in each clone (A2) andwas
also the case for mFFA4-PD-eYFP expressed in the arrestin2/3-null background (A2). B, parental and Gq/G11-null HEK293 cells expressing hFFA4-mVenus
were also stimulated with vehicle or TUG-891 (10 M, 5 min). Phosphorylation of the receptor was detected with a human FFA4 specific anti-phospho
Thr347-Ser350 antiserum (21), and the co-addition of anti--tubulin antibodies provided loading controls (B1). B2, quantification of the extent of agonist-
induced phosphorylation was produced by densitometric analysis of three experiments, each performed on samples derived from separate cell treatments:
ns not significantly different. C, HEK293 andGq/G11-null cells expressing hFFA4-mVenuswere challengedwith 3M TUG-891 in single-cell imaging Ca
2
experiments. D, calcium mobilization experiments were performed on populations of parental HEK293 and Gq/G11-null cells expressing the mFFA4-eYFP
construct. These demonstrated that mFFA4-mediated Ca2 release was lost in the absence of Gq/G11.
x
x
x
x
x
x
x
x
x
x
x
FIGURE 3. FFA4-mediated inositol phosphate generation is lacking in
Gq/G11-null HEK293 cells. Parental and Gq/G11-null HEK293 cells sta-
bly expressing human (A) or mouse (B) FFA4were used tomeasure basal and
TUG-891-mediated levels of inositol monophosphates.
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(Fig. 6A, Table 1). Indeed, in these two final situationswhere the
PD form of the mFFA4 receptor was expressed, the addition of
ATP 12 min after the addition of TUG-891 was able to induce
only a very modest further elevation of [Ca2]i because levels
still remained markedly elevated over basal at this time (Fig.
6B). This was in contrast to parental HEK293 cells expressing
wild type mFFA4-eYFP or, indeed, arrestin2/3-null cells
expressing wild type mFFA4-eYFP where, because Ca2 levels
had returned to basal, the addition of ATP now produced as
robust a response as did the initial application of TUG-891 (Fig.
6C). Equally of note: although a single application of TUG-891
in parental HEK293 cells was able to largely desensitize
mFFA4-eYFP to subsequent additions of the agonist after
washout, in arrestin2/3-null cells response to TUG-891 did not
desensitize across multiple washes and re-additions of the
ligand (Fig. 6C). Analysis of these signals in the arrestin2/3-null
cells showed that the initial peak of Ca2 did, however, reflect a
greater extent of release than in the parental HEK293 cells,
which possibly reflects the extended kinetics of Ca2 elevation
in this cellular background (Table 2). Further peaks displayed
similar, but a somewhat smaller, extent of release than the ini-
tial peak (Table 2). After a single addition of TUG-891 in arres-
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FIGURE 4. Effects of elimination of GqG11 or arrestin2 arrestin3 on agonist-induced internalization of FFA4. A, parental (i, iii, and iv), Gq/G11-
null (ii and vii), or arrestin2/3-null (v and vi) HEK293 cells stably expressingmFFA4-eYFP (i–iii and v) or mFFA4-PD-eYFP (iv and vi–vii) were exposed to TUG-891
(10 M) (upper panels, t 0; lower panels, t 30 min). In iii, the Gq/G11 inhibitor YM-254890 (100 nM) was added 30 min before the addition of TUG-891.
Representative images of experiments performed at least three times are shown. B, cell surface ELISA experimentswere performed todetect the FLAG-epitope
tag introduced into the extracellular N-terminal domain on each form of FFA4 at various times after the addition of TUG-891. 100% represents receptor at the
cell surface before the addition of TUG-891. Agonist-induced internalizationwas observed at the 30-min time point (**, p 0.01; ***, p 0.001). The extent of
internalization of mFFA4-eYFP was greater (p 0.001) in parental than in arrestin2/3-null HEK293 cells. ns not significantly different from t 0.
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tin2/3-null cells expressing wild type FFA4-eYFP, multiple
individual spikes of Ca2 release were produced in a repeated
and non-synchronized manner across individual cells analyzed
(Fig. 7A). This was not observed in parental HEK293 cells
expressing wild type mFFA4-eYFP. where such repetitive spik-
ing of Ca2 release was largely absent (Fig. 7B).
Complexity of FFA4 Activation of ERK1/2 Signaling Revealed
by Genome-edited HEK293 Cells—In parental HEK293 cells
expressing mFFA4-eYFP, the addition of TUG-891 also stimu-
lated ERK1/2 phosphorylation. This signal, whichwas relatively
modest, peaked within 5 min of agonist addition and then
decayed to basal levels (Fig. 8A). This was mediated by Gq/
G11, as it was lacking when these cells were pretreated with
YM-254890 (Fig. 8A). The role of Gq/G11 was confirmed
because TUG-891 was also completely unable to promote
ERK1/2 phosphorylation in Gq/G11-null cells expressing
mFFA4-eYFP (Fig. 8A). By contrast, in arrestin2/3-null cells
expressing mFFA4-eYFP TUG-891 also increased ERK1/2
phosphorylation. In these cells signal also peaked at 5min post-
agonist addition and although slightly more sustained than in
the parental HEK293 cell background (Fig. 8A) was quantita-
tively no larger at peak (Fig. 8A). Interestingly, expression of
mFFA4-PD-eYFP in the parental HEK293 cell background
resulted in a much more quantitatively robust stimulation of
ERK1/2 phosphorylation in response to TUG-891 than pro-
duced by thewild type receptor (Fig. 8B) (note differences in the
scale of the y axis in Fig. 8, A and B). Although also peaking 5
min after the addition of agonist, ERK1/2 phosphorylation
remained elevated over at least a 30-min period in this setting
(Fig. 8B). Once again, however, this was all but attenuated by
pretreatmentwithYM-254890 (Fig. 8B). This latter feature sug-
FIGURE 5. Reintroduction of arrestin3 into arrestin2/3-null HEK293 cells
restored agonist-mediated internalization of FFA4. Parental (A) or arres-
tin2/3-null (B) HEK293 cells stably expressing mFFA4-eYFP were transfected
transiently to express arrestin3-mCherry and treated with TUG-891 (10 M)
(upper panels: t 0; lower panels: t 30 min). Representative images of the
location ofmFFA4-eYFP (yellow channel) and arrestin3-mCherry (red channel)
are shown. In the right-hand panels these images aremerged to provide color
overlap.
FIGURE 6. Lack of arrestin2/3 and resistance to agonist-induced receptor
phosphorylation extended the kinetics of Ca2 elevation in HEK293
cells. Intracellular Ca2 levels and how these were affected over time by
TUG-891-induced activation of FFA4 were assessed in a series of single cell
Ca2 imaging studies performed in both parental and arrestin2/3-null
HEK293 cells expressing either wild type or mFFA4-PD as indicated. A, repre-
sentative traces in parental HEK293 cells expressing wild type mFFA4
(HEK293-mFFA4-eYFP), parental cells expressing mFFA4-PD (HEK293-mFFA4-
PD-eYFP), arrestin2/3-null cells expressing wild type mFFA4 (Arr2/3-null-
mFFA4-eYFP), and arrestin2/3-null cells expressing mFFA4-PD (Arr2/3-null-
mFFA4-PD-eYFP). B, shows data from studies on parental and arrestin2/3-null
HEK293 cells expressing mFFA4-PD in which after the addition and washout
of two treatments with TUG-891 ATP was added at 760 s to activate endoge-
nously expressed P2Y receptors. C, a single exposure to TUG-891 was suffi-
cient to fully desensitizemFFA4 in parental HEK293 cells but not in arrestin2/
3-null cells. Time(s) of addition of TUG-891 is shown as are subsequent
additions of ATP.
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gested that ERK1/2 phosphorylation, which in other systems
can be promoted by a range of G protein-dependent and non-
canonical, G protein-independent, pathways, was mediated
exclusively via activation of Gq/G11 in this cell background.
However, although exceptionally modest compared with the
effect in wild type HEK293 cells, in Gq/G11-null cells
mFFA4-PD-eYFP was able to cause a 2-fold elevation of
ERK1/2 phosphorylation (Fig. 8B). Interestingly, this effect was
not ablated by treatment with Pertussis toxin (Fig. 8B),
although in some settings activation of FFA4 can generate sig-
nals and functions via pertussis toxin-sensitive,Gi familyGpro-
teins (16, 32). Finally, we assessed if mFFA4-PD-eYFPwould be
able to regulate ERK1/2 phosphorylation in the absence of
arrestins. Indeed, TUG-891 produced extremely robust activa-
tion in this setting (Fig. 8B). Therefore, rather than promoting
ERK1/2 phosphorylation in the context of HEK293 cells via
expressed FFA4, arrestins appear to provide a negative con-
straint on FFA4 regulation of this end point.
Discussion
Here we have employed novel CRISPR/Cas9 genome-edited
HEK293 cells in which expression of either Gq and G11 or
arrestin2 and arrestin3 was eliminated, in combination with a
phosphorylation-deficient GPCR variant to dissect the relative
contributions of G protein-, arrestin-, and receptor phosphor-
ylation-dependent pathways to signaling of the FFA4 receptor.
In so doing we have not only revealed an otherwise unappreci-
ated complexity of FFA4 regulation of ERK1/2 signaling but we
have provided important validation and characterization of the
genome-edited cell lines.We anticipate that these cell lines will
become widely used by the community to study the signaling
modalities of other GPCRs, because HEK293 cells have been
one of the most important model systems for such work over
many years.
Although arrestins were named initially for their capacity to
arrest or limit the duration and intensity of G protein-mediated
signaling by binding to agonist-occupied GPCRs (3) and in so
doing prevented simultaneous interactionswith heterotrimeric
G proteins, in recent years considerable focus has been given to
distinct roles of the arrestins to promote overlapping or alter-
nate signaling cascades (3). Observations of effects in cells and
tissues of arrestin knock-out mouse lines (5) have provided
clear support for roles of arrestins that extendwell beyond their
initially defined role in receptor desensitization. Despite such
understanding, many studies that explore the mechanistic
details of such potential non-Gprotein-mediated effects of ago-
nist actions at GPCRs have centered on the use of model cell
systems, not least HEK293 cells (11–14). In substantial part this
reflects on the ease of transfection of plasmids designed to
either reduce the levels of expression of arrestin isoforms via
induced degradation of the corresponding mRNA or to pro-
duce “dominant negative” proteins designed to sequester
arrestin-interacting proteins. However, by their nature, such
approaches can only result in partial and incomplete effects,
and this can cloud the interpretation of data. In the current
studies we have, therefore, taken advantage of recent revolu-
tions in genome-editing to generate HEK293 cells that lack
expression of the ubiquitously expressed arrestin isoforms,
arrestin2 and arrestin3. Although it is often assumed that these
two isoforms are functionally redundant, it is important to note
that evidence is emerging that they may play non-overlapping
roles (33, 34). Subsequently, we introduced either mouse or
human FFA4 receptor into the arrestin2/3-null cells as well as
into parental HEK293 cells and, after isolation of individual
A
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FIGURE 7. Repetitive Ca2 spiking in arrestin2/3-null HEK293 cells re-
flected a lack of FFA4 desensitization. Arrestin2/3-null (A) and parental (B)
HEK293 cells expressing mFFA4-eYFP were exposed to a single, maintained
concentrationof TUG-891 (3M) at the indicatedpoint. Studies across 25 cells
analyzed in single-cell Ca2 imaging studies were overlaid. At the indicated
time ATP (100 M) was added.
TABLE 1
Kinetics of Ca2 elevation in genome-edited HEK293 cells
The speed at which the initial peak of Ca2 decays over time was analyzed and
compared between the four cell lines using a one-phase decay equation (Fig. 6A).
From this half-life (t1⁄2) was assessed as a measure of how rapidly the signal declined
over time and the Tau constant, as a measure of the rate constant for this change.
Cell line t1/2
Tau
constant
s s
HEK293-mFFA4-eYFP 21.5 30.9
HEK293-mFFA4-PD-eYFP 497.2 717.3
Arr2/3-null-mFFA4-eYFP 66.6 96.1
Arr2/3-null-mFFA4-PD-eYFP 259.2 374.0
TABLE 2
Comparison of the area under the curve from single-cell Ca2 experiments
Traces from cells illustrated in Fig. 6C were analyzed and subsequently compared by calculating the area under the curve of the first and only peak in the case of the
HEK293-mFFA4-eYFP and the initial and subsequent peaks in the Arr2/3-null-mFFA4-eYFP expressing cells.
Cell line
HEK293
Initial peak
Arr2/3-null
Initial peak
Arr2/3-null
peak 2
Arr2/3-null
peak 3
Arr2/3-null
peak 4
Total area (ratio s) 10.1 26.0 20.5 20.8 19.3
G Protein Versus Arrestin GPCR-mediated Signaling
27154 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 291•NUMBER 53•DECEMBER 30, 2016
 at G
lasgow
 U
niversity Library on M
arch 17, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
clones, then compared responsiveness after the addition of the
FFA4 synthetic agonist TUG-891 (25, 26). FFA4 is a GPCR that
responds to medium and longer chain free fatty acids and is
considered a potential therapeutic target for various metabolic
disorders, including type II diabetes (16, 35). It is generally con-
sidered as a receptor that couples with high selectivity to the
members of the Gq/G11 G protein subfamily to elevate intracel-
lular Ca2 subsequent to phosphoinositidase C-mediated pro-
duction of inositol 1,4,5 trisphosphate, and as such, we also
expressed forms of FFA4 into HEK293 cells that had been
genome-edited to eliminate expression of both Gq and G11.
This was designed to provide controls for G protein-mediated
signaling, but as YM-254890 is a very effective and selective
inhibitor of these G proteins (28–31), we also employed this
reagent to help dissect contributions from these regulators.
Importantly, elimination of expression of either Gq and G11
or arrestin2 and arrestin3 did not result in significant changes
in expression levels of other G protein  subunits or in levels of
Gq/G11 in the arrestin2/3-null cells. It is well appreciated
that in mouse gene knock-out models there is potential for
some level of compensatory changes in protein expression pat-
terns linked to the sustained lack of specific gene products.
This, however, is more likely to be the case in such knock-out
animals, in which there are physiologically relevant pressures
for adaptation and compensation than in transformed cell lines
such as HEK293 cells.
Aswell as interacting effectivelywithGq and/orG11, FFA4
also interacts strongly with arrestins in an agonist-dependent
manner (21, 22, 26, 27). In large part this relies on the phosphor-
ylation of two clusters of serine and threonine residues located
in the intracellular C-terminal tail of the receptor (21, 22, 36).
We previously mapped the sites of phosphorylation induced by
the addition of the synthetic FFA4 agonist TUG-891 and
altered all of these to alanines (21, 22). By so doing, althoughnot
entirely eliminated, agonist-induced interaction between FFA4
and arrestins is greatly reduced (21, 22). As such we also
expressed a PD variant of mFFA4 in each of parental, arrestin2/
3-null and Gq/G11-null HEK293, cells to explore aspects of
similarity or difference between an FFA4 receptor variant that
cannot be phosphorylated and the wild type receptor that can-
not interact with arrestins simply due to the lack of expression
of these proteins.
Importantly for validation of the broader usefulness of these
cells, a number of the results obtained were as predicted from
previous studies. In the absence of Gq/G11, the addition of
TUG-891 did not elevate the levels of inositol phosphates and,
as such, also failed to elevate intracellular Ca2 levels. However,
despite this lack ofGprotein engagement, agonist occupancy of
FFA4 did result in conformational changes in the receptor that
allowed it to become phosphorylated, which would normally
act as a prelude to interactions with arrestins (37). This was
measured by immunoblotting samples with antisera that iden-
tify specifically FFA4 (either human or mouse) when amino
acids Thr347 and Ser350 become phosphorylated (21, 22). That
this occurred in Gq/G11-null HEK293 cells as well as in
parental cells indicates this does not reflect activation of protein
kinase C (PKC), although PKC, as well as G protein-coupled
receptor kinase 6 (GRK6) has previously been shown to have
capacity to cause phosphorylation of FFA4 (36), and both are
expressed by HEK293 cells (38). Moreover, in accord with
expectations from earlier studies with other receptors (39, 40),
a lack of Gq/G11 did not interfere with agonist-mediated
internalization of FFA4 in response to the addition of agonist
nor indeed did inhibition of function of these G proteins with
the chemical inhibitor YM-254890. The absence of arrestins,
however, largely blocked agonist-induced internalization of
wild type FFA4, and the samewas true for the PD-FFA4 variant,
whether expressed in parental or in arrestin2/3-null HEK293
cells.
Questions of the contribution of arrestins to GPCR-medi-
ated phosphorylation and activation of the ERK1/2 MAP
kinases have been studied for many years, initiated in signifi-
cant part by data from HEK293 cells transiently transfected to
express the 2-adrenoreceptor. In part, this reflects the central
role of these kinases as a regulatory hub for cellular signaling
from both GPCRs and tyrosine kinase receptors. However, a
central element of focus on the ERK1/2 MAP kinases also, in
part, reflects the availability of high quality antisera able to
detect phosphorylated and, therefore, activated forms of these
kinases. This has resulted in many semiquantitative studies in
which immunoblots to detect levels of phosphorylated ERK1/2
are compared before and after a cellular challenge. These stud-
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FIGURE8.FFA4-PDgeneratedenhancedactivationof ERK1/2MAPkinase
phosphorylation largely via Gq/G11-mediated signals. ERK1/2 phos-
phorylation studies were performed using wild type (A) or mFFA4-PD-eYFP
(B) stably expressed in each of parental, Gq/G11-null, and arrestin2/3-null
HEK293 cells. In certain experiments the Gq  G11 inhibitor YM-254890
(YM, 100 nM) was added 30 min before the agonist TUG-891. In other studies
cells were pretreatedwith pertussis toxin (PTX) overnight before the addition
of TUG-891. ERK1/2 phosphorylation was measured at the indicated time
points and is presented as -fold over basal. NOTE: the different scale of the y
axis in A and B.
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ies implicated temporally separable early and later waves of
ERK1/2 MAP kinase phosphorylation as reflecting G protein
and arrestin-mediated engagement, respectively (41). Herein,
stimulation of parental HEK293 cells expressing FFA4 resulted
in a rapidly produced peak of ERK1/2 phosphorylation, which
was modest in extent and returned rapidly to near basal levels.
This was clearly mediated largely by Gq/G11, as it was
blocked by preaddition of YM-254890 andwas completely lack-
ing in Gq/G11-null cells expressing the wild type receptor.
Arrestin2/3-null HEK293 cells expressing wild type receptor
displayed a similarly modest peak and profile of TUG-891-in-
duced ERK1/2 phosphorylation as observed in the wild type
HEK293 cell background. Muchmore notably, in parental cells
expressing mFFA4-PD, the addition of TUG-891 resulted in an
equivalently rapid but much larger peak of ERK1/2 phosphor-
ylation than in the cells expressing wild type FFA4, which
although reduced within 10 min, reached a new plateau level
akin to the pattern often attributed to arrestin-mediated signal-
ing. However, this was also all but eliminated by treatment with
YM-254890, suggesting it to also reflect Gq/G11-mediated
signaling.Moreover, themuch higher immediate peak and sus-
tained plateau of ERK1/2 phosphorylation was also observed in
arrestin2/3-nullHEK293 cells expressing FFA4-PD.To assess if
there was a component of the ERK1/2 activation that was not
related directly to Gq/G11, we closely examined the effects in
Gq/G11-null HEK293 cells. Here, although no response
could be detected for wild type FFA4, a modest but detectable
effect was recorded in such cells expressing FFA4-PD.To assess
the mechanism of this effect, we treated these cells with the Gi
G protein-family inhibitor pertussis toxin because at least in
certain cell types physiologically relevant signals from FFA4
have been shown to be blocked by pertussis toxin treatment (16,
32). Treatment with pertussis toxin was, however, unable to
completely eliminate the phosphorylation of ERK1/2 in this
setting. This would suggest a Gi-independent mechanism
that remains to be elucidated. Previous studies using siRNA-
induced knockdown of arrestins in HEK293 cells indicated this
to result in enhanced stimulation of ERK1/2 phosphorylation
by the endogenously expressed muscarinic M3 receptor (38).
This implies that different class A GPCRs may well employ
different strategies to engage and regulate this key hub of signal
integration.
Overall, the results provided herein suggest that in aHEK293
cell background, arrestin engagement with FFA4 does not
result in a non-canonical pathway to ERK1/2 activation.
Instead, the enhanced signals of FFA4-PD suggest that a lack of
phosphorylation and poor engagement with arrestins and,
potentially, the very restricted ability of this receptor to inter-
nalize results inmore extensive andmore prolongedG protein-
mediated signals that maintain ERK1/2 phosphorylation. To
assess this more fully we considered the extent and kinetics of
Ca2 signaling as a monitor of potential receptor desensitiza-
tion. We have previously shown that in HEK293 cells FFA4
desensitizes rapidly to a single pulse of agonist but that this can
also be reversed rapidly with agonist washout (26). Herein, we
first confirmed rapid and profound desensitization of Ca2
elevation in response to TUG-891 in parental HEK293 cells
expressing the wild type mouse receptor. In contrast, in
arrestin2/3-null cells, such desensitization did not occur,
and repeated pulses of TUG-891 caused subsequent pulses
of Ca2 elevation. This was noticeable in the arrestin2/3-null
cells, even with a single pulse of TUG-891; whereas the time
to peak of Ca2 release was not distinct from that observed
in parental HEK293 cells, the time for recovery to basal was
markedly extended. Clearly, measured levels of [Ca2]i
reflect a balance between release and re-uptake from intra-
cellular stores. Rapid, indeed almost immediate, FFA4 phos-
phorylation and desensitization would allow rapid return to
basal in the presence of effective re-uptake. By contrast,
although re-uptake may be unchanged, limited desensitiza-
tion in the arrestin2/3-null cells implies ongoing release that
will result in elevated levels being maintained for longer.
This was markedly extended in both parental and arrestin2/
3-null cells. Now, indeed [Ca2]i levels were maintained at
greatly elevated levels for10 min. This suggests that FFA4-
PD, able to interact at best weakly with arrestins and main-
tained at the cell surface, can continue to signal via Gq/
G11 over a sustained period, and thus the cells are unable to
return to a basal equilibrium with maintained low [Ca2]i.
That this was not nearly as pronounced in arrestin2/3-null
cells expressing wild type FFA4 does suggest, however, that
arrestins are not the only contributors to the function and
regulation of FFA4 despite it being well established that this
receptor interacts in a sustained fashion with arrestins and,
in cells with a wild type background, is able to internalize
into endosomes in concert with an arrestin (26).
The rapid progress of approaches in genome editing is now
primed to offer ways to understand roles of specific compo-
nents of signaling pathways as well as ways to assess potential
off-target effects of activators and inhibitors of proteins within
such pathways. The current studies show that, at least in the
background of HEK293 cells, arrestins play a more important
role in the functions of FFA4 as traditional arresting molecules
of canonical G protein-mediated signals than as non-canonical
signal initiators, as we have been unable to detect a role for
arrestins in promoting ERK1/2 activation after stimulation of
the FFA4 receptor.
Experimental Procedures
Materials—Unless otherwise stated, all chemicals and re-
agents were from Sigma. Tissue culture reagents and buffers
were fromLife Technologies Inc. TUG-891 (3-(4-((4-fluoro-4-
methyl-[1,1-biphenyl]-2-yl)methoxy)phenyl)-propanoic acid)
was as described previously (25–27). Cellular signaling assay
kits (IP-One and pERK1/2) were obtained from Cisbio Bioas-
says (Codolet, France). Antisera for the detection of arrestin2
(product number #12697) and arrestin3 (product number
#3857) were purchased from Cell Signaling (Nottingham, UK),
and anti--tubulin antibody (product number T9026) was pur-
chased from Sigma, whereas Gq/G11 Gs, Gi1/2, and GFP
antisera were produced in house. Phospho-site- specific anti-
sera were raised against the peptide GAIFT(P)DTS(P)VRRND.
which corresponds to amino acids 343–357 of mouse (m)FFA4
(22) and KGAILT(P)DTS(P)VKR for human (h)FFA4 (21).
IREDye 800CW or IREDye 680 RD secondary antibodies
were from LI-COR (Cambridge, UK). Protease and phospha-
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tase inhibitor cocktails were from Roche Applied Science.
YM-254890 was a kind gift of Astellas Pharma Inc. (Osaka,
Japan).
Plasmids and Mutagenesis—All of the FFA4 constructs
tagged with eYFP were generated as previously described (21,
22, 26, 27). Briefly, the wild type or PD FFA4 receptors were
fused at their C terminus to eYFP and to an N-terminal FLAG
epitope and subsequently subcloned into pcDNA3.1 for con-
stitutive expression. The identity of all new constructs gen-
erated was verified by nucleotide sequencing. In certain
cases eYFP was replaced with monomeric Venus fluorescent
protein (mVenus).
Generation of Gq/G11 and Arrestin2/3-null Cells—Gener-
ation of HEK293 cells devoid of functional Gq and G11 was
previously described (23). Expression from the genes for arres-
tin2 and arrestin3 was also eliminated using a similar strategy
that will be reported in detail elsewhere.
Cell Lines—Parental HEK293, Gq/G11-null, and arrestin2/
3-null HEK293 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), penicillin (100 unitsml	1), and streptomycin
(100 mgml	1) at 37 °C and 5% CO2 in a humidified atmos-
phere. Parental, Gq/G11-null HEK293, and arrestin2/3-
null HEK293 cells were transfected with either 5 g of the wild
type FFA4 receptors (FFA4-eYFP) or the phospho-deficient
forms of FFA4 (FFA4-PD-eYFP) plasmids in a 1:6 ratio using
polyethyleneimine. After 24 h cells were serially diluted into
10-cm dishes where foci were allow to grow under selection
withDMEMsupplementedwithGeneticin (Promega). Individ-
ual clones were isolated and screened for homogeneous eYFP/
mVenus expression. A single clone per cell line was selected for
subsequent experiments.
HTRF-based IP1 and ERK1/2 Phosphorylation Assays—IP1
assays (Cisbio Bioassays) were performed according to the
manufacturer’s instructions. In brief, a suspension of 7500
cells/well was incubated with the stated concentrations of ago-
nist for 1 h in the presence of 10 mM lithium chloride. IP1
accumulation was subsequently measured using a PHERAstar
FS plate reader (BMG Labtech, Offenburg, Germany). Quanti-
fication of phosphorylated ERK1/2 levels was performed using
the phospho-ERK (Thr202/Tyr204) cellular assay kit (Cisbio Bio-
assays). Cells were plated at 45,000 cells/well in poly-D-lysine-
coated 96-well plates and on the day of the experiment were
incubated with FBS-free medium for 4 h, after which they were
treated with compounds and inhibitors for the stated times.
After removal of these, 50 l of lysis buffer was added to each
well, and plates were incubated for 30 min on an orbital shaker
at room temperature. 16 l of cell lysates were transferred to a
white 384-well proxi-plate and incubated in the dark for 2 h at
room temperature with anti-phospho-ERK1/2-d2 (2 l) and
anti-phospho-ERK1/2-Eu3-cryptate (2 l). Time-resolved
fluorescence resonance energy transfer signals were measured
using a PHERAstar FS plate reader.
Western Blotting—Cell lysates, membrane preparations, or
cytosolic fractions were size-fractionated on 4–12% SDS-
PAGE gels and transferred to nitrocellulosemembranes. Nitro-
cellulose membranes containing resolved receptor proteins
were incubated in phosphate-buffered saline or Tris-buffered
saline LI-COR blocking buffer and incubated subsequently
with the stated antibody/antiserumdilutions.Membraneswere
air-dried and scanned using an LI-COR Odyssey CLx Imager
(Cambridge, UK) for the detection of polypeptides.
Single Cell Calcium Imaging—Cells stably expressing the
FFA4-eYFP constructs were cultured on 0 thickness poly-D-
lysine-coated glass coverslips for 24 h in complete DMEM. Sin-
gle-cell Ca2measurements in cells loadedwith Fura-2AMdye
were then performed as described previously (42).
Visualization of FFA4 Internalization—Cells expressing the
various mFFA4-eYFP/mVenus constructs were cultured on
poly-D-lysine-coated glass coverslips and cultured for 24 h. Live
cells were transferred to Hanks’ balanced salt solution and then
imaged using a Zeiss VivaTome spinning disk confocal micros-
copy system (Karl Zeiss, Oberkochen, Germany). Images on at
least 7 z-sections were taken before the addition of ligand and
every 5 min after ligand addition for a total of 30 min.
Cell Surface ELISA—HEK293 cell variants expressing the dif-
ferent constructs were cultured on poly-D-lysine-coated flat-
bottom96-well plates for 24 h and cultured in FBS-freemedium
for 4 h and with ligand for the indicated times after which cells
were fixed using 4% paraformaldehyde, 0.3 M sucrose solution.
These were subsequently incubated in phosphate-buffered
saline containing 5% bovine serum albumin to block nonspe-
cific binding sites (30 min at room temperature) followed by
incubation with an anti-FLAG monoclonal primary antibody
(product number #T6199) (30 min at room temperature) and
finally with an anti-mouse horseradish peroxidase-conjugated
secondary antibody (30 min at room temperature). Cells were
washed 3 times with phosphate-buffered saline before measur-
ing Hoechst 33342 fluorescence using a PolarStar Omega plate
reader. After washing a final time with phosphate-buffered
saline and incubating with 3,3,5,5-tetramethylbenzidine
horseradish peroxidase substrate in the dark at room tempera-
ture, the absorbance at 620 nm was measured on a PHERAstar
FS plate reader. Receptor surface expression was calculated as
the 620-nm absorbance corrected for cell number based on
Hoechst fluorescence.
Data Analysis—All data present represent the means S.E.
of at least three independent experiments. Data analysis and
curve fitting was carried out using the Graphpad Prism soft-
ware package v5.0b (GraphPad Software, La Jolla, CA). Analysis
of images was carried out using either the Image Studio lite v5.2
(LI-COR, Cambridge, UK) or ImageJ/Fiji software (43).
Author Contributions—G. M. and A. B. T. conceived this work. A. I.
generated reagents. E. A.-C., L. J., S. Z. R., and R. P. performed the
experiments. G. M., E. A.-C., and A. B. T. wrote the paper with assis-
tance from all authors.
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